Phase II study of a full-dose THP-COP regimen for aggressive non-Hodgkin lymphoma in the elderly
Phase 2
- Conditions
- aggressive non Hodgkin lymphoma
- Registration Number
- JPRN-UMIN000005636
- Lead Sponsor
- Hematological Malignancy Clinical Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with any other malignancies 2)mental illness 3)a history of myocardial infarction or angina 4)central nervous system infiltration 5)uncontrollable diabetes 6)human immunodeficiency virus infection 7) hepatitis B virus surface antigen 8)hepatitis C virus antibody positivity
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method